Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
106.45
+1.19 (+1.13%)
Official Closing Price
Updated: 4:10 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,991,977
Open
105.53
Bid (Size)
106.01 (500)
Ask (Size)
106.62 (100)
Prev. Close
105.26
Today's Range
104.43 - 106.62
52wk Range
73.31 - 107.59
Shares Outstanding
2,531,374,696
Dividend Yield
3.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
Today 12:10 EST
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations
Today 11:55 EST
As the opening bells of 2026 ring across Wall Street, Bank of America Securities has released its highly anticipated "Top 10 U.S. Stock Ideas for Q1 2026." The report, a cornerstone for institutional...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Performance
YTD
N/A
N/A
1 Month
+5.4%
+5.4%
3 Month
+18.9%
+18.9%
6 Month
+31.5%
+31.5%
1 Year
+7.3%
+7.3%
More News
Read More
Generating Yield in a Sideways Market: The Strategic Rise of Dow Jones Covered Call ETFs
January 01, 2026
Via
MarketMinute
Topics
ETFs
Economy
Regulatory Compliance
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
January 01, 2026
Via
MarketMinute
Topics
Intellectual Property
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Top gainers and losers in the S&P500 index during Monday's after-hours session.
↗
December 29, 2025
Via
Chartmill
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
December 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Earnings
3 Drug Stocks to Buy at a Discount
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Dynavax Turnaround: From Clinical Setbacks to a $2.2 Billion Exit
December 26, 2025
Via
PredictStreet
Merck & Co. Inc. (NYSE:MRK) Emerges as a Top Quality Investing Candidate
↗
December 26, 2025
Via
Chartmill
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Great Vaccine Consolidation: Sanofi’s $2.2 Billion Strategic Bet on Dynavax Technologies
December 25, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
December 25, 2025
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025
December 24, 2025
Via
MarketMinute
Topics
Bonds
Earnings
World Trade
Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
December 24, 2025
Via
PredictStreet
Topics
Initial Public Offering
Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
December 24, 2025
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition
December 24, 2025
Via
PredictStreet
Topics
Economy
Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring
December 24, 2025
Via
MarketMinute
Topics
Intellectual Property
Top 5 US Healthcare Stocks By Market Value
↗
December 24, 2025
Via
Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
December 23, 2025
Via
MarketMinute
Topics
Economy
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 106.45
When was Merck & Co last traded?
The last trade of Merck & Co was at 01/02/26 04:10 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 269.46B
How many shares of Merck & Co are outstanding?
Merck & Co has 269B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.